146 related articles for article (PubMed ID: 18408083)
1. The use of infliximab in ocular inflammation.
Prendiville C; O'Doherty M; Moriarty P; Cassidy L
Br J Ophthalmol; 2008 Jun; 92(6):823-5. PubMed ID: 18408083
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.
Garrity JA; Coleman AW; Matteson EL; Eggenberger ER; Waitzman DM
Am J Ophthalmol; 2004 Dec; 138(6):925-30. PubMed ID: 15629282
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
Farvardin M; Afarid M; Mehryar M; Hosseini H
Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for treatment of ocular inflammatory disease: a series of four cases.
Kurz PA; Suhler EB; Choi D; Rosenbaum JT
Br J Ophthalmol; 2009 Apr; 93(4):546-8. PubMed ID: 19321476
[TBL] [Abstract][Full Text] [Related]
6. Orbital lobular panniculitis in Weber-Christian disease: sustained response to anti-TNF treatment and review of the literature.
Mavrikakis I; Georgiadis T; Fragiadaki K; Sfikakis PP
Surv Ophthalmol; 2010; 55(6):584-9. PubMed ID: 20701939
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.
Petropoulos IK; Vaudaux JD; Guex-Crosier Y
Klin Monbl Augenheilkd; 2008 May; 225(5):457-61. PubMed ID: 18454398
[TBL] [Abstract][Full Text] [Related]
8. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
[TBL] [Abstract][Full Text] [Related]
9. Infliximab in relapsing polychondritis.
de Barros AP; Nakamura NA; Santana Tde F; Motta JQ; Bianchi WA
Rev Bras Reumatol; 2010; 50(2):211-6. PubMed ID: 21125156
[TBL] [Abstract][Full Text] [Related]
10. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
Sobrin L; Kim EC; Christen W; Papadaki T; Letko E; Foster CS
Arch Ophthalmol; 2007 Jul; 125(7):895-900. PubMed ID: 17620567
[TBL] [Abstract][Full Text] [Related]
11. Infliximab treatment for anal fistula in patients with Crohn's disease.
Higashi D; Futami K; Egawa Y; Hirano K; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kuroki H; Maekawa T; Ono Y; Matsui T
Anticancer Res; 2009 Mar; 29(3):927-33. PubMed ID: 19414329
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with infliximab in a patient with Diffuse Subretinal Fibrosis syndrome.
Adán A; Sanmartí R; Burés A; Casaroli-Marano RP
Am J Ophthalmol; 2007 Mar; 143(3):533-4. PubMed ID: 17317410
[TBL] [Abstract][Full Text] [Related]
13. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
[TBL] [Abstract][Full Text] [Related]
14. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
Jabbarvand M; Fard MA
Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal anti-TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy.
Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Kłysik A; Goś R; Majos A; Stefańczyk L; Stepień H
Klin Oczna; 2007; 109(10-12):457-60. PubMed ID: 18488396
[TBL] [Abstract][Full Text] [Related]
16. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
Wang Y; Gaudio PA
Ocul Immunol Inflamm; 2008; 16(4):167-71. PubMed ID: 18716952
[TBL] [Abstract][Full Text] [Related]
17. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
18. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
19. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
Simonini G; Zannin ME; Caputo R; Falcini F; de Martino M; Zulian F; Cimaz R
Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma.
Deveci F; Muz MH; Ilhan N; Kirkil G; Turgut T; Akpolat N
Respirology; 2008 Jun; 13(4):488-97. PubMed ID: 18410261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
